A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
Transdermal buprenorphine in clinical practice: a multicenter, noninterventional postmarketing study in the Czech Republic
2012
Pain Management
Preserved Fulltext
To evaluate the use of transdermal buprenorphine patches (Transtec®) in routine clinical practice. A prospective, noninterventional, postmarketing study performed in the Czech Republic by 71 investigators in various clinical practice settings. Patients with chronic moderate-to-severe cancer pain, or chronic severe noncancer pain insufficiently controlled by nonopioids, were prescribed buprenorphine transdermal patch 35, 52.5 or 70 µg/h, and evaluated for 3 months. Additional analgesia and
doi:10.2217/pmt.11.93
pmid:24645818
fatcat:z6c6rphh4nep5pasb3lg6nweom